Last reviewed · How we verify
NCT06712329
Chronic Plantar Fasciitis: Which is More Effective? Prolotherapy/Extracorporeal Shock Wave Therapy?
NA trial testing extracorporeal shock wave therapy in Chronic Plantar Fasciitis in 70 participants. Completed in 19 December 2024.
19 December 2024
Quick facts
| Lead sponsor | Ankara City Hospital Bilkent |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 70 |
| Start date | 1 October 2023 |
| Primary completion | 19 December 2024 |
| Estimated completion | 19 December 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- extracorporeal shock wave therapy
- Prolotherapy — full drug profile →
Conditions studied
- Chronic Plantar Fasciitis — all drugs for Chronic Plantar Fasciitis →
Sponsor
Ankara City Hospital Bilkent
Who can join
Adults 18 to 75, any sex, with Chronic Plantar Fasciitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this prospective study was to compare the effects of ESWT (extracorporeal shock wave therapy ) and prolotherapy on pain and foot function in patients with chronic plantar fasciitis. In addition, the study was to investigate the changes in plantar pressure distribution and plantar fascia thickness measured by ultrasonography after ESWT and prolotherapy. The fundamental questions that investigators want to answer are as follows: \[question 1\]:Do ESWT and prolotherapy improve pain and foot function in patients with chronic plantar fasciitis? \[question 2\]:Do ESWT and prolotherapy change plantar pressure distribution and plantar fascia thickness in patients with chronic plantar fasciitis?
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06712329
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of extracorporeal shock wave therapy
Trials testing the same drug.
- NCT06603181 — Effect of Extracorporeal Shock Wave Therapy (ESWT) and Phonophoresis Treatment in Patients With Lateral Epicondylitis · NA · completed
- NCT07245498 — ESWT for Low Back Pain · NA · completed
- NCT06717633 — Comparison of Short-term Effects of Extracorporeal Shock Wave Therapy, Low-level Laser Therapy and Pulsed Electromagneti · Phase 3 · unknown
- NCT06301152 — Lateral Epicondylitis Treatment High Intensive Laser Therapy and Extracorporeal Shock Wave Therapy · NA · completed
- NCT03792945 — Comparison of the Efficacy of Corticosteroid Injection and ESWT in Patients With CTS · Phase 4 · completed
Other recruiting trials for Chronic Plantar Fasciitis
Currently open trials in the same condition.
- NCT05162144 — Proximal Medial Gastriocnemius Recession for Chronic Plantar Fasciitis · NA · active not recruiting
Other Ankara City Hospital Bilkent trials
Trials by the same sponsor.
- NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
- NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
- NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
- NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
- NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06712329 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
- Last refreshed: 27 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06712329.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing